Antiulcer agents and medications for acid peptic disease are commonly used drugs that rarely cause liver injury. Both classes of antiulcer medications block the pathways of acid production or secretion, decreasing gastric acidity, improving symptoms and aiding in healing of acid-peptic diseases. The most common remedy is a combination of antibiotic drugs to kill the H. pylori bacteria and medications to get rid of acid in your stomach. These typically include proton pump inhibitors (like Aciphex or Nexium), and antibiotics.
MARKET DYNAMICS
The anti-peptic ulcer drugs market is driving due to the growing prevalence of chronic diseases and cancer and the increasing demand for cell therapies for the treatment of these diseases. growth during the forecast period. Moreover, the rising preference of patients to consume drugs instead of surgical procedure is driving the market growth in the forecast period.
MARKET SCOPE
The "Anti-Peptic Ulcer Drugs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-peptic ulcer drugs market with detailed market segmentation by product, and application. The anti-peptic ulcer drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-peptic ulcer drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The anti-peptic ulcer drugs market is segmented on the basis of product and application. Based on product, the market is segmented as proton pump inhibitors (PPIs), potassium-competitive acid blockers (P-CAB), antacids, h2 antagonists and ulcer protective drugs. On the basis of application, the market is categorized as gastritis, gastric ulcers, duodenal ulcers and gastroesophageal reflux disease (GERD).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-peptic ulcer drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-peptic ulcer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting anti peptic ulcer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-peptic ulcer drugs market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-peptic ulcer drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-peptic ulcer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting anti peptic ulcer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-peptic ulcer drugs market in these regions.
MARKET PLAYERS
The report covers key developments in the anti -peptic ulcer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti peptic ulcer drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-peptic ulcer drugs in the global market. Below mentioned is the list of few companies engaged in the anti-peptic ulcer drugs market.
The report also includes the profiles of key players in anti-peptic ulcer drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AstraZeneca
- Ask-pharm
- Takeda
- Yangtze River Pharm
- Shandong Luoxin
- HUADONG MEDICINE CO.,LTD
- Changzhou Siyao
- Beijing Yuekang
- Guangdong Dahua
- Xian Janssen
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti Peptic Ulcer Drugs Market - By Product
1.3.2 Anti Peptic Ulcer Drugs Market - By Application
1.3.3 Anti Peptic Ulcer Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI PEPTIC ULCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI PEPTIC ULCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI PEPTIC ULCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI PEPTIC ULCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTI PEPTIC ULCER DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI PEPTIC ULCER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PROTON PUMP INHIBITORS (PPIS)
7.3.1. Overview
7.3.2. Proton Pump Inhibitors (PPIs) Market Forecast and Analysis
7.4. POTASSIUM-COMPETITIVE ACID BLOCKERS (P-CAB)
7.4.1. Overview
7.4.2. Potassium-Competitive Acid Blockers (P-CAB) Market Forecast and Analysis
7.5. ANTACIDS
7.5.1. Overview
7.5.2. Antacids Market Forecast and Analysis
7.6. H2 ANTAGONISTS
7.6.1. Overview
7.6.2. H2 Antagonists Market Forecast and Analysis
7.7. ULCER PROTECTIVE DRUGS
7.7.1. Overview
7.7.2. Ulcer Protective Drugs Market Forecast and Analysis
8. ANTI PEPTIC ULCER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GASTRITIS
8.3.1. Overview
8.3.2. Gastritis Market Forecast and Analysis
8.4. GASTRIC ULCERS
8.4.1. Overview
8.4.2. Gastric Ulcers Market Forecast and Analysis
8.5. DUODENAL ULCERS
8.5.1. Overview
8.5.2. Duodenal Ulcers Market Forecast and Analysis
8.6. GASTROESOPHAGEAL REFLUX DISEASE (GERD)
8.6.1. Overview
8.6.2. Gastroesophageal Reflux Disease (GERD) Market Forecast and Analysis
9. ANTI PEPTIC ULCER DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anti Peptic Ulcer Drugs Market Overview
9.1.2 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.1.3 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anti Peptic Ulcer Drugs Market
9.1.5.1.1 United States Anti Peptic Ulcer Drugs Market by Product
9.1.5.1.2 United States Anti Peptic Ulcer Drugs Market by Application
9.1.5.2 Canada Anti Peptic Ulcer Drugs Market
9.1.5.2.1 Canada Anti Peptic Ulcer Drugs Market by Product
9.1.5.2.2 Canada Anti Peptic Ulcer Drugs Market by Application
9.1.5.3 Mexico Anti Peptic Ulcer Drugs Market
9.1.5.3.1 Mexico Anti Peptic Ulcer Drugs Market by Product
9.1.5.3.2 Mexico Anti Peptic Ulcer Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Anti Peptic Ulcer Drugs Market Overview
9.2.2 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.2.3 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti Peptic Ulcer Drugs Market
9.2.5.1.1 Germany Anti Peptic Ulcer Drugs Market by Product
9.2.5.1.2 Germany Anti Peptic Ulcer Drugs Market by Application
9.2.5.2 France Anti Peptic Ulcer Drugs Market
9.2.5.2.1 France Anti Peptic Ulcer Drugs Market by Product
9.2.5.2.2 France Anti Peptic Ulcer Drugs Market by Application
9.2.5.3 Italy Anti Peptic Ulcer Drugs Market
9.2.5.3.1 Italy Anti Peptic Ulcer Drugs Market by Product
9.2.5.3.2 Italy Anti Peptic Ulcer Drugs Market by Application
9.2.5.4 Spain Anti Peptic Ulcer Drugs Market
9.2.5.4.1 Spain Anti Peptic Ulcer Drugs Market by Product
9.2.5.4.2 Spain Anti Peptic Ulcer Drugs Market by Application
9.2.5.5 United Kingdom Anti Peptic Ulcer Drugs Market
9.2.5.5.1 United Kingdom Anti Peptic Ulcer Drugs Market by Product
9.2.5.5.2 United Kingdom Anti Peptic Ulcer Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anti Peptic Ulcer Drugs Market Overview
9.3.2 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anti Peptic Ulcer Drugs Market
9.3.5.1.1 Australia Anti Peptic Ulcer Drugs Market by Product
9.3.5.1.2 Australia Anti Peptic Ulcer Drugs Market by Application
9.3.5.2 China Anti Peptic Ulcer Drugs Market
9.3.5.2.1 China Anti Peptic Ulcer Drugs Market by Product
9.3.5.2.2 China Anti Peptic Ulcer Drugs Market by Application
9.3.5.3 India Anti Peptic Ulcer Drugs Market
9.3.5.3.1 India Anti Peptic Ulcer Drugs Market by Product
9.3.5.3.2 India Anti Peptic Ulcer Drugs Market by Application
9.3.5.4 Japan Anti Peptic Ulcer Drugs Market
9.3.5.4.1 Japan Anti Peptic Ulcer Drugs Market by Product
9.3.5.4.2 Japan Anti Peptic Ulcer Drugs Market by Application
9.3.5.5 South Korea Anti Peptic Ulcer Drugs Market
9.3.5.5.1 South Korea Anti Peptic Ulcer Drugs Market by Product
9.3.5.5.2 South Korea Anti Peptic Ulcer Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anti Peptic Ulcer Drugs Market Overview
9.4.2 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anti Peptic Ulcer Drugs Market
9.4.5.1.1 South Africa Anti Peptic Ulcer Drugs Market by Product
9.4.5.1.2 South Africa Anti Peptic Ulcer Drugs Market by Application
9.4.5.2 Saudi Arabia Anti Peptic Ulcer Drugs Market
9.4.5.2.1 Saudi Arabia Anti Peptic Ulcer Drugs Market by Product
9.4.5.2.2 Saudi Arabia Anti Peptic Ulcer Drugs Market by Application
9.4.5.3 U.A.E Anti Peptic Ulcer Drugs Market
9.4.5.3.1 U.A.E Anti Peptic Ulcer Drugs Market by Product
9.4.5.3.2 U.A.E Anti Peptic Ulcer Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anti Peptic Ulcer Drugs Market Overview
9.5.2 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.5.3 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anti Peptic Ulcer Drugs Market
9.5.5.1.1 Brazil Anti Peptic Ulcer Drugs Market by Product
9.5.5.1.2 Brazil Anti Peptic Ulcer Drugs Market by Application
9.5.5.2 Argentina Anti Peptic Ulcer Drugs Market
9.5.5.2.1 Argentina Anti Peptic Ulcer Drugs Market by Product
9.5.5.2.2 Argentina Anti Peptic Ulcer Drugs Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTI PEPTIC ULCER DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTI PEPTIC ULCER DRUGS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASK-PHARM
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TAKEDA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. YANGTZE RIVER PHARM
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SHANDONG LUOXIN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HUADONG MEDICINE CO.,LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CHANGZHOU SIYAO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BEIJING YUEKANG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GUANGDONG DAHUA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. XIAN JANSSEN
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. AstraZeneca
2. Ask-pharm
3. Takeda
4. Yangtze River Pharm
5. Shandong Luoxin
6. HUADONG MEDICINE CO.,LTD
7. Changzhou Siyao
8. Beijing Yuekang
9. Guangdong Dahua
10. Xian Janssen
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Anti-Peptic Ulcer Drugs Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)